Your session is about to expire
← Back to Search
CD34+ Stem Cell Infusion for Post-Bone Marrow Transplant Care
Study Summary
This trial is for patients who have had a stem cell transplant and are not doing well afterwards. The goal is to provide them with access to a Miltenyi device which will help their cells function better.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- N/AMy stem cell transplant did not work well or at all.
- Group 1: CD34 Positive Stem Cell Infusion
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are actively engaged in this clinical experiment?
"Affirmative. According to clinicaltrials.gov, this healthcare investigation is actively enrolling participants since its inception on May 6th 2015 and latest update on May 25th 2022. 75 people are being sought after from a single site."
Are new participants being accepted into this investigation?
"Affirmative. Per the information on clinicaltrials.gov, this experiment is actively searching for qualified participants and was initially posted on May 6th 2015. Last updated on May 25th 2022, it aims to enroll 75 individuals from one medical facility."
Share this study with friends
Copy Link
Messenger